Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
Stopped early
Conditions studied: Epidermolysis Bullosa Dystrophica
In brief
Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a severe inherited blistering skin disease caused by absence of type VII collagen. Patients with RDEB develop large, severly painful blisters and open wounds from minor trauma to their skin. In the future, we hope to start a gene transfer study on a specific group of RDEB subjects and we are screening subjects for that potential trial now.
Key facts
- Study ID
- NCT00533572
- Run by
- Stanford University
- People needed
- 1
- Starts
- 2007-08-01
- Expected to finish
- 2008-08-01
- Last updated by the study team
- 2015-05-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.